{"nct_id":"NCT03558139","title":"Study of Magrolimab (Hu5F9-G4) in Combination With Avelumab in Solid Tumor Participants and Checkpoint-Inhibitor-Naive Ovarian Cancer Participants Who Progress Within 6 Months of Prior Platinum Chemotherapy","status":"COMPLETED","status_verified_date":"2023-09","start_date":"2018-05-23","start_date_type":"ACTUAL","primary_completion_date":"2020-12-03","primary_completion_date_type":"ACTUAL","completion_date":"2020-12-03","completion_date_type":"ACTUAL","phases":["PHASE1"],"tickers":["GILD"]}